JPRN-C000000424未知2 期
Pharmacogenomic study of modified FOLFOX6 (combination chemotherapy of Oxaliplatin with infusional 5-FU/l-Leucovorin) in colorectal cancer - Pharmacogenomic study of modified FOLFOX6 in colorectal cancer
Development Organization for Frontier Medical Therapeutics0 个研究点目标入组 60 人开始时间: 2006年6月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Symptomatic infectious disease (2)Watery diarrhea (3)Ileus, obstructive bowel disease (4)Interstitial pneumonia, pulmonary fibrosis (5)Symptomatic malignant ascites, pleural or pericardial effusion (6)Peripheral neuropathy >= grade 2 (DEB-NTC) (7)Ischemic heart disease or arrhythmia required medical care (8)Myocardiac infarction occurred within 6 months (9)Liver cirrhosis (10)Hemorrhage, GI-Select >= grade 3 (NCI-CTC) (11)Symptomatic psychological disease (12)Uncontrollable diabetes (13)Active secondary malignancies (14)A past history of severe drug allergy (15)Concomitant therapy with phenytoin or warfarin potassium (16)Pregnancy or breast feeding (17)Other severe comorbid condition
研究者
相似试验
已完成
2 期
Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.Colorectal CancerJPRN-UMIN000001490Yakult Honsha Co.,Ltd.65
进行中（未招募）
不适用
RANDOMISED COMPARATIVE STUDY OF FOLFOX6m PLUS SIR-SPHERES MICROSPHERES VERSUS FOLFOX6m ALONE AS FIRST LINE TREATMENT IN PATIENTS WITH NONRESECTABLE LIVER METASTASES FROM PRIMARY COLORECTAL CARCINOMA - SIRFLOX studyEUCTR2008-003737-25-ITSIRTEX TECHNOLOGY PTY LTD318
已完成
2 期
Safety and efficacy of Alternating mFOLFOX6 and FOLFIRI every 4cycles as First line Therapy in Advanced colorectal Cancernresectable advanced/recurrent colorectal cancerJPRN-UMIN000001340KSCC47
进行中（未招募）
1 期
Randomised comparative study of folfox6m plus SIR-Spheres microspheres versus folfox6m alone as first line treatment in patients with non-resectable liver metastases from primary colorectal carcinomaon-resectable liver metastasis from primary colorectal carcinomaMedDRA version: 17.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864Non-resectable liver metastasis from primary colorectal carcinomaEUCTR2008-003737-25-DESirtex Technology Pty Ltd570
已完成
2 期
Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal CancerColon CancerNCT00193219SCRI Development Innovations, LLC36